245 related articles for article (PubMed ID: 30140943)
1. Comparison of brachytherapy and external beam radiotherapy boost in breast-conserving therapy: Patient-reported outcome measures and aesthetic outcome.
Kindts I; Laenen A; Christiaens M; Janssen H; Van Limbergen E; Weltens C
Strahlenther Onkol; 2019 Jan; 195(1):21-31. PubMed ID: 30140943
[TBL] [Abstract][Full Text] [Related]
2. A comparison of a brachytherapy and an external beam radiotherapy boost in breast-conserving therapy for breast cancer: local and any recurrences.
Kindts I; Verhoeven K; Laenen A; Christiaens M; Janssen H; Van der Vorst A; Van Limbergen E; Weltens C
Strahlenther Onkol; 2019 Apr; 195(4):310-317. PubMed ID: 30603857
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
[TBL] [Abstract][Full Text] [Related]
4. The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy.
Lansu JT; Essers M; Voogd AC; Luiten EJ; Buijs C; Groenendaal N; Poortmans PM
Eur J Surg Oncol; 2015 Oct; 41(10):1411-6. PubMed ID: 26260375
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
6. A comparison of three different radiotherapy boost techniques after breast conserving therapy for breast cancer.
Verhoeven K; Kindts I; Laenen A; Peeters S; Janssen H; Van Limbergen E; Weltens C
Breast; 2015 Aug; 24(4):391-6. PubMed ID: 25819427
[TBL] [Abstract][Full Text] [Related]
7. PROMs following breast-conserving therapy for breast cancer: results from a prospective longitudinal monocentric study.
Kindts I; Laenen A; van den Akker M; Weltens C
Support Care Cancer; 2019 Nov; 27(11):4123-4132. PubMed ID: 30790047
[TBL] [Abstract][Full Text] [Related]
8. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.
Ciabattoni A; Gregucci F; Fastner G; Cavuto S; Spera A; Drago S; Ziegler I; Mirri MA; Consorti R; Sedlmayer F
Breast Cancer Res; 2021 Apr; 23(1):46. PubMed ID: 33849606
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: Final outcomes of a randomized controlled trial (COBALT).
Volders JH; Haloua MH; Krekel NM; Negenborn VL; Kolk RH; Lopes Cardozo AM; Bosch AM; de Widt-Levert LM; van der Veen H; Rijna H; Taets van Amerongen AH; Jóźwiak K; Meijer S; van den Tol MP
Eur J Surg Oncol; 2017 Apr; 43(4):649-657. PubMed ID: 27916314
[TBL] [Abstract][Full Text] [Related]
10. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.
Poortmans P; Bartelink H; Horiot JC; Struikmans H; Van den Bogaert W; Fourquet A; Jager J; Hoogenraad W; Rodrigus P; Wárlám-Rodenhuis C; Collette L; Pierart M;
Radiother Oncol; 2004 Jul; 72(1):25-33. PubMed ID: 15236871
[TBL] [Abstract][Full Text] [Related]
11. A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer.
Garsa AA; Ferraro DJ; DeWees TA; Deshields TL; Margenthaler JA; Cyr AE; Naughton M; Aft R; Gillanders WE; Eberlein T; Matesa MA; Ochoa LL; Zoberi I
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1043-50. PubMed ID: 24161428
[TBL] [Abstract][Full Text] [Related]
12. Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.
Brouwers PJAM; van Werkhoven E; Bartelink H; Fourquet A; Lemanski C; van Loon J; Maduro JH; Russell NS; Scheijmans LJEE; Schinagl DAX; Westenberg AH; Poortmans P; Boersma LJ;
Radiother Oncol; 2018 Sep; 128(3):434-441. PubMed ID: 29980320
[TBL] [Abstract][Full Text] [Related]
13. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
14. Effect of cosmetic outcome on quality of life after breast cancer surgery.
Kim MK; Kim T; Moon HG; Jin US; Kim K; Kim J; Lee JW; Kim J; Lee E; Yoo TK; Noh DY; Minn KW; Han W
Eur J Surg Oncol; 2015 Mar; 41(3):426-32. PubMed ID: 25578249
[TBL] [Abstract][Full Text] [Related]
15. Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial.
Merie R; Browne L; Cardoso JS; Cardoso MJ; Chin Y; Clark C; Graham P; Szwajcer A; Hau E
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):819-825. PubMed ID: 28834326
[TBL] [Abstract][Full Text] [Related]
16. Cosmetic outcome and quality of life are inextricably linked in breast-conserving therapy.
Volders JH; Negenborn VL; Haloua MH; Krekel NMA; Jóźwiak K; Meijer S; M van den Tol P
J Surg Oncol; 2017 Jun; 115(8):941-948. PubMed ID: 28334419
[TBL] [Abstract][Full Text] [Related]
17. Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™.
Dahlbäck C; Ullmark JH; Rehn M; Ringberg A; Manjer J
Breast Cancer Res Treat; 2017 Aug; 164(3):679-687. PubMed ID: 28536951
[TBL] [Abstract][Full Text] [Related]
18. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
Guerrero M; Li XA
Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
[TBL] [Abstract][Full Text] [Related]
19. One-step intraoperative radiotherapy optimizes conservative treatment of breast cancer with advantages in quality of life and work resumption.
Sorrentino L; Fissi S; Meaglia I; Bossi D; Caserini O; Mazzucchelli S; Truffi M; Albasini S; Tabarelli P; Liotta M; Ivaldi GB; Corsi F
Breast; 2018 Jun; 39():123-130. PubMed ID: 29674010
[TBL] [Abstract][Full Text] [Related]
20. Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer.
Resch A; Pötter R; Van Limbergen E; Biber E; Klein T; Fellner C; Handl-Zeller L; Langbauer G; Schürer-Waldheim H; Staffen A; Jakesz R; Kubista E; Lehr S; Seitz W
Radiother Oncol; 2002 Apr; 63(1):47-58. PubMed ID: 12065103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
